Tenecteplase biosimilar (Reliance Life Sciences)

替奈普酶生物类似药 (Reliance Life Sciences)

Report date: 2025/06/11 09:29:03

Base Information

Drug NameTenecteplase biosimilar (Reliance Life Sciences)

Drug Alias NameTenecteRelR-TPR-012

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionPlasminogen activators

TargetsPlasminogen

Therapy Area/IndicationsIschemic StrokeST Elevation Myocardial InfarctionMyocardial Infarction

Global Approved IndicationsMyocardial Infarction

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2020/07/04

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesReliance Life Sciences

China Registration ClassN/A

Develop Information

Active CompaniesReliance Life Sciences

Inactive CompaniesN/A

Active IndicationsIschemic StrokeST Elevation Myocardial InfarctionMyocardial Infarction

Inactive IndicationsN/A

Other Information

ATC CodeN/A